1. Home
  2. PLSE vs LMB Comparison

PLSE vs LMB Comparison

Compare PLSE & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • LMB
  • Stock Information
  • Founded
  • PLSE 2014
  • LMB 1901
  • Country
  • PLSE United States
  • LMB United States
  • Employees
  • PLSE N/A
  • LMB N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • LMB Engineering & Construction
  • Sector
  • PLSE Health Care
  • LMB Consumer Discretionary
  • Exchange
  • PLSE Nasdaq
  • LMB Nasdaq
  • Market Cap
  • PLSE 1.2B
  • LMB 1.2B
  • IPO Year
  • PLSE 2016
  • LMB 2014
  • Fundamental
  • Price
  • PLSE $16.93
  • LMB $94.48
  • Analyst Decision
  • PLSE Buy
  • LMB Strong Buy
  • Analyst Count
  • PLSE 1
  • LMB 3
  • Target Price
  • PLSE $22.00
  • LMB $130.33
  • AVG Volume (30 Days)
  • PLSE 138.8K
  • LMB 153.8K
  • Earning Date
  • PLSE 11-05-2025
  • LMB 11-04-2025
  • Dividend Yield
  • PLSE N/A
  • LMB N/A
  • EPS Growth
  • PLSE N/A
  • LMB 35.95
  • EPS
  • PLSE N/A
  • LMB 2.92
  • Revenue
  • PLSE N/A
  • LMB $552,919,000.00
  • Revenue This Year
  • PLSE N/A
  • LMB $28.57
  • Revenue Next Year
  • PLSE $700.00
  • LMB $14.48
  • P/E Ratio
  • PLSE N/A
  • LMB $32.37
  • Revenue Growth
  • PLSE N/A
  • LMB 8.06
  • 52 Week Low
  • PLSE $13.77
  • LMB $63.02
  • 52 Week High
  • PLSE $25.00
  • LMB $154.05
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 43.70
  • LMB 46.14
  • Support Level
  • PLSE $17.10
  • LMB $93.33
  • Resistance Level
  • PLSE $18.35
  • LMB $100.79
  • Average True Range (ATR)
  • PLSE 0.65
  • LMB 4.71
  • MACD
  • PLSE -0.17
  • LMB 0.82
  • Stochastic Oscillator
  • PLSE 16.16
  • LMB 37.89

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.

Share on Social Networks: